Ratio Therapeutics

Ratio Therapeutics is a pioneering pharmaceutical company focused on developing best-in-class radiopharmaceuticals for cancer treatment. Utilizing innovative technologies like their Trillium™ targeting scaffold, Ratio Therapeutics creates targeted radiotherapeutics that leverage pharmacokinetic modulation and advanced chelation techniques. The company aims to accelerate the selection of compounds through early clinical phases, combining imaging and therapeutic capabilities in a de-risked platform designed to tackle a diverse array of cancer targets.